BSc (Manchester), PhD (Cantab)
- Postdoctoral Affiliate
Originally from Germany, Dr Carolin Sauer moved to the UK in 2013 and graduated with a first-class BSc (Hons) in Biology from the University of Manchester. Subsequently, Dr Sauer moved to Cambridge to complete her PhD in Medical Sciences at the Cancer Research UK Cambridge Institute, University of Cambridge. During this time, Dr Sauer was working in Prof. Brenton’s Functional Genomics of Ovarian Cancer laboratory, focussing her research on understanding the genomic complexity and chromosomal instability observed in ovarian cancers. Her thesis entitled Biomarkers of Genome Instability and Disease Progression in Ovarian Cancer has been nominated for the Milo Keynes Thesis Prize at the School of Clinical Medicine and received a DRA Honourable Mention Award. Dr Sauer is now a Postdoctoral Fellow in the Cortés-Ciriano group at the European Bioinformatics Institute (EMBL-EBI).
Dr Carolin Sauer is currently investigating novel approaches for the study of cancer genomics and early cancer detection. Thereby, Dr Sauer’s main research interest is the application of emerging DNA sequencing technologies for the detection of cancer-specific genomic and epigenomic aberrations in liquid biopsies. Her research vision is that these approaches could be used for the early diagnosis, monitoring and molecular profiling of cancers and is driven by the overarching aim of improving outcomes for patients with childhood and adult malignancies.